Search Results Search Sort by RelevanceMost Recent Art of Medicine May 2019 Fading Mind of a Patient With Alzheimer’s Laci Hadorn This artwork represents—via a puzzle—physical and emotional experiences of brain deterioration. AMA J Ethics. 2019;21(5):E455-456. doi: 10.1001/amajethics.2019.455. Case and Commentary Dec 2019 How Should “CRISPRed” Babies Be Monitored Over Their Life Course to Promote Health Equity? Charis Thompson, PhD Transnational monitoring efforts should focus on safety, defining standard of care, and promoting just access to innovation. AMA J Ethics. 2019;21(12):E1036-1041. doi: 10.1001/amajethics.2019.1036. Case and Commentary Mar 2005 Transition of Care Jonathan Spahr, MD and Don Hayes, Jr, MD Virtual Mentor. 2005;7(3):218-221. doi: 10.1001/virtualmentor.2005.7.3.ccas3-0503. Health Law Dec 2016 The Legal Implications of Detecting Alzheimer’s Disease Earlier Joshua Preston, Jaleh McTeigue, Caitlin Opperman, Jordan Dean Scott Krieg, Mikaela Brandt-Fontaine, Alina Yasis, and Francis X. Shen, JD, PhD What are insurance, contract, and criminal law implications of detecting Alzheimer’s disease early? AMA J Ethics. 2016;18(12):1207-1217. doi: 10.1001/journalofethics.2016.18.12.hlaw1-1612. Case and Commentary Jun 2016 When Is Depression a Terminal Illness? Deliberative Suicide in Chronic Mental Illness Constance E. George, MD, MA In some cases, hope might not have substantial ethical or therapeutic value. AMA J Ethics. 2016;18(6):594-600. doi: 10.1001/journalofethics.2016.18.6.ecas4-1606. Medicine and Society Aug 2004 Presymptomatic Genetic Testing for Neurodegenerative Diseases Shane K. Green, PhD Virtual Mentor. 2004;6(8):360-363. doi: 10.1001/virtualmentor.2004.6.8.msoc1-0408. Policy Forum Aug 2016 Ethical Considerations about EHR-Mediated Results Disclosure and Pathology Information Presented via Patient Portals Kristina A. Davis, MD and Lauren B. Smith, MD An emerging medical ethics issue is whether to delay posting pathology reports to electronic health records (EHR) to allow clinicians time to follow up. AMA J Ethics. 2016;18(8):826-832. doi: 10.1001/journalofethics.2016.18.8.pfor1-1608. In the Literature Jun 2003 Race, Genomics, and Health Care Faith Lagay, PhD Virtual Mentor. 2003;5(6):211-214. doi: 10.1001/virtualmentor.2003.5.6.jdsc1-0306. Policy Forum Mar 2016 Shedding Privacy Along with our Genetic Material: What Constitutes Adequate Legal Protection against Surreptitious Genetic Testing? Nicolle K. Strand, JD, MBioethics Law doesn’t always adequately address unauthorized uses of individuals’ DNA. Ethics can help establish legal privacy protections that work. AMA J Ethics. 2016;18(3):264-271. doi: 10.1001/journalofethics.2016.18.3.pfor2-1603. Medicine and Society Oct 2023 What Might Aducanumab Teach Us About Clinicians’ Judgment About Whether to Recommend Emerging Alzheimer’s Interventions? Adam W. Burroughs, MD and Lewis P. Krain, MD Ethics questions about care of patients with AD could influence clinicians’ judgment about whether and when to recommend aducanumab. AMA J Ethics. 2023;25(10):E777-782. doi: 10.1001/amajethics.2023.777. Pagination Current page 1 Page 2 Page 3 Page 4 Page 5 Next page Next › Last page Last »
Art of Medicine May 2019 Fading Mind of a Patient With Alzheimer’s Laci Hadorn This artwork represents—via a puzzle—physical and emotional experiences of brain deterioration. AMA J Ethics. 2019;21(5):E455-456. doi: 10.1001/amajethics.2019.455.
Case and Commentary Dec 2019 How Should “CRISPRed” Babies Be Monitored Over Their Life Course to Promote Health Equity? Charis Thompson, PhD Transnational monitoring efforts should focus on safety, defining standard of care, and promoting just access to innovation. AMA J Ethics. 2019;21(12):E1036-1041. doi: 10.1001/amajethics.2019.1036.
Case and Commentary Mar 2005 Transition of Care Jonathan Spahr, MD and Don Hayes, Jr, MD Virtual Mentor. 2005;7(3):218-221. doi: 10.1001/virtualmentor.2005.7.3.ccas3-0503.
Health Law Dec 2016 The Legal Implications of Detecting Alzheimer’s Disease Earlier Joshua Preston, Jaleh McTeigue, Caitlin Opperman, Jordan Dean Scott Krieg, Mikaela Brandt-Fontaine, Alina Yasis, and Francis X. Shen, JD, PhD What are insurance, contract, and criminal law implications of detecting Alzheimer’s disease early? AMA J Ethics. 2016;18(12):1207-1217. doi: 10.1001/journalofethics.2016.18.12.hlaw1-1612.
Case and Commentary Jun 2016 When Is Depression a Terminal Illness? Deliberative Suicide in Chronic Mental Illness Constance E. George, MD, MA In some cases, hope might not have substantial ethical or therapeutic value. AMA J Ethics. 2016;18(6):594-600. doi: 10.1001/journalofethics.2016.18.6.ecas4-1606.
Medicine and Society Aug 2004 Presymptomatic Genetic Testing for Neurodegenerative Diseases Shane K. Green, PhD Virtual Mentor. 2004;6(8):360-363. doi: 10.1001/virtualmentor.2004.6.8.msoc1-0408.
Policy Forum Aug 2016 Ethical Considerations about EHR-Mediated Results Disclosure and Pathology Information Presented via Patient Portals Kristina A. Davis, MD and Lauren B. Smith, MD An emerging medical ethics issue is whether to delay posting pathology reports to electronic health records (EHR) to allow clinicians time to follow up. AMA J Ethics. 2016;18(8):826-832. doi: 10.1001/journalofethics.2016.18.8.pfor1-1608.
In the Literature Jun 2003 Race, Genomics, and Health Care Faith Lagay, PhD Virtual Mentor. 2003;5(6):211-214. doi: 10.1001/virtualmentor.2003.5.6.jdsc1-0306.
Policy Forum Mar 2016 Shedding Privacy Along with our Genetic Material: What Constitutes Adequate Legal Protection against Surreptitious Genetic Testing? Nicolle K. Strand, JD, MBioethics Law doesn’t always adequately address unauthorized uses of individuals’ DNA. Ethics can help establish legal privacy protections that work. AMA J Ethics. 2016;18(3):264-271. doi: 10.1001/journalofethics.2016.18.3.pfor2-1603.
Medicine and Society Oct 2023 What Might Aducanumab Teach Us About Clinicians’ Judgment About Whether to Recommend Emerging Alzheimer’s Interventions? Adam W. Burroughs, MD and Lewis P. Krain, MD Ethics questions about care of patients with AD could influence clinicians’ judgment about whether and when to recommend aducanumab. AMA J Ethics. 2023;25(10):E777-782. doi: 10.1001/amajethics.2023.777.